| James D Taylor Md Inc | |
|
155 Andersen Dr Ste 1108 San Rafael CA 94901-3999 | |
| (415) 455-0914 | |
| (415) 454-4315 |
| Full Name | James D Taylor Md Inc |
|---|---|
| Speciality | Internal Medicine |
| Location | 155 Andersen Dr Ste 1108, San Rafael, California |
| Authorized Official Name and Position | James Taylor (OWNER) |
| Authorized Official Contact | 4154550914 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| James D Taylor Md Inc 155 Andersen Dr Ste 1108 San Rafael CA 94901-3999 Ph: (415) 455-0914 | James D Taylor Md Inc 155 Andersen Dr Ste 1108 San Rafael CA 94901-3999 Ph: (415) 455-0914 |
| NPI Number | 1326386897 |
|---|---|
| Provider Enumeration Date | 01/17/2013 |
| Last Update Date | 01/17/2013 |
| Medicare PECOS PAC ID | 5193970705 |
|---|---|
| Medicare Enrollment ID | O20130306000112 |
News Archive
Obesity and obstructive sleep apnea (OSA) tend to co-exist and are associated with high blood pressure. The effects of weight loss and continuous positive airway pressure (CPAP), the standard therapy for OSA, on blood pressure have been previously studied individually, but the incremental benefit of combination therapy (weight loss and CPAP therapy) over either therapy alone in obese patients with OSA has been unknown.
Golden Valley Development, Inc. is pleased to announce the development of the PERCUGUARD needlestick prevention device, a tool currently unavailable in the medical and dental industries, exceeding 1 billion potential annual applications worldwide.
Studies have shown that family history is a risk factor for COPD, but have not accounted for family history of smoking. Researchers from Brigham and Women's Hospital, the University of Colorado, and National Jewish Health compared 821 COPD cases with 776 control smokers from the COPD Gene Study, capturing parental smoking and COPD histories, along with environmental tobacco smoke exposure.
A survey of 25,000 Romanians with diabetes has revealed that diabetic neuropathy (DN), a complication of diabetes, is highly prevalent in these patients, even in the absence of a diagnostic, and has an important impact on patients' quality of life.
CorMedix Inc. today announced that it has received CE Mark approval for Neutrolin, a catheter lock solution, for patients with central venous catheters on hemodialysis secondary to advanced chronic kidney disease.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326386897 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | G62102 (California) | Primary |
| Provider Name | James D Taylor |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1801825328 PECOS PAC ID: 1052225125 Enrollment ID: I20031113000763 |
News Archive
Obesity and obstructive sleep apnea (OSA) tend to co-exist and are associated with high blood pressure. The effects of weight loss and continuous positive airway pressure (CPAP), the standard therapy for OSA, on blood pressure have been previously studied individually, but the incremental benefit of combination therapy (weight loss and CPAP therapy) over either therapy alone in obese patients with OSA has been unknown.
Golden Valley Development, Inc. is pleased to announce the development of the PERCUGUARD needlestick prevention device, a tool currently unavailable in the medical and dental industries, exceeding 1 billion potential annual applications worldwide.
Studies have shown that family history is a risk factor for COPD, but have not accounted for family history of smoking. Researchers from Brigham and Women's Hospital, the University of Colorado, and National Jewish Health compared 821 COPD cases with 776 control smokers from the COPD Gene Study, capturing parental smoking and COPD histories, along with environmental tobacco smoke exposure.
A survey of 25,000 Romanians with diabetes has revealed that diabetic neuropathy (DN), a complication of diabetes, is highly prevalent in these patients, even in the absence of a diagnostic, and has an important impact on patients' quality of life.
CorMedix Inc. today announced that it has received CE Mark approval for Neutrolin, a catheter lock solution, for patients with central venous catheters on hemodialysis secondary to advanced chronic kidney disease.
› Verified 1 days ago
News Archive
Obesity and obstructive sleep apnea (OSA) tend to co-exist and are associated with high blood pressure. The effects of weight loss and continuous positive airway pressure (CPAP), the standard therapy for OSA, on blood pressure have been previously studied individually, but the incremental benefit of combination therapy (weight loss and CPAP therapy) over either therapy alone in obese patients with OSA has been unknown.
Golden Valley Development, Inc. is pleased to announce the development of the PERCUGUARD needlestick prevention device, a tool currently unavailable in the medical and dental industries, exceeding 1 billion potential annual applications worldwide.
Studies have shown that family history is a risk factor for COPD, but have not accounted for family history of smoking. Researchers from Brigham and Women's Hospital, the University of Colorado, and National Jewish Health compared 821 COPD cases with 776 control smokers from the COPD Gene Study, capturing parental smoking and COPD histories, along with environmental tobacco smoke exposure.
A survey of 25,000 Romanians with diabetes has revealed that diabetic neuropathy (DN), a complication of diabetes, is highly prevalent in these patients, even in the absence of a diagnostic, and has an important impact on patients' quality of life.
CorMedix Inc. today announced that it has received CE Mark approval for Neutrolin, a catheter lock solution, for patients with central venous catheters on hemodialysis secondary to advanced chronic kidney disease.
› Verified 1 days ago
Rimon Issac D.o. Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 18 Ninestone Ct, San Rafael, CA 94903 Phone: 415-472-3730 | |
Marin Community Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 411 4th Strteet, Suite A, San Rafael, CA 94901 Phone: 415-798-3106 Fax: 415-798-3104 | |
Sally Daganzo, Md Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1050 Northgate Dr Ste 500, San Rafael, CA 94903 Phone: 415-249-2580 Fax: 415-728-0375 | |
Sutter Pacific Medical Foundation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 750 Las Gallinas Ave, #210, San Rafael, CA 94903 Phone: 415-479-7244 Fax: 415-479-0917 | |
Prima Medical Group, Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4000 Civic Center Dr, #200b, San Rafael, CA 94903 Phone: 415-492-3333 Fax: 415-492-3425 | |
Marin Community Clinic Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 3110 Kerner Blvd, San Rafael, CA 94901 Phone: 415-526-8500 Fax: 415-526-8553 | |
Glow Health Medical Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 655 Irwin St # B1013, San Rafael, CA 94901 Phone: 415-287-2920 |